Tirofiban Combined With Aspirin in Moderate Ischemic Stroke
A phase 4 trial registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 1168 participants.
Also called NCT07760922
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 1,168 participants
- Registry
-
NCT07760922
-
- Planned start
- (anticipated)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- China
- Registry status
- Not yet recruiting
Technical summary
Registry record NCT07760922. Randomized; quadruple masking; primary purpose treatment. Start 2026-10-01 (anticipated); primary completion 2028-12-31 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Tirofiban Combined With Aspirin in Moderate Ischemic Stroke
- Condition
- Ischemic Stroke, Acute
- Intervention (Drug)
- Tirofiban
- Intervention (Drug)
- Tirofiban-matching placebo
- Lead sponsor
- Xinqiao Hospital of Chongqing
- Collaborator
- The First Affiliated Hospital of Nanchang University
Record details
- Record id
cardio:ct-nct07760922- Content hash
bf67a72cde48a93d2516a34869a4a8f4c7a0f2811d794508168f37ad01b5a02e